Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA HEALTH GROUP INC.

中國醫療集團有限公司

(Carrying on business in Hong Kong as "萬全醫療集團") ( Incorporated in the Cayman Islands with limited liability)

(Stock Code: 08225)

POLL RESULTS OF THE EXTRAORDINARY GENERAL

MEETING HELD ON 12 JULY 2022

The Board is pleased to announce that the proposed resolution as set out in the Notice was duly passed by the Independent Shareholders by way of poll at the EGM held on 12 July 2022.

Reference is made to the circular incorporating the notice (the "Notice") of the extraordinary general meeting held on 12 July 2022 (the "EGM") of China Health Group Inc. (the "Company") dated 24 June 2022 in relation to the New Framework Service Agreement of the continuing connected transaction (the "Circular"). Unless the context otherwise requires, capitalised terms used in this announcement shall have the same meanings as those defined in the Circular.

POLL RESULT OF THE EGM

The resolution set out in the "Notice" was passed by poll at the extraordinary general meeting held on 12 July 2022. Ms. Zhang Aizhen (Ms. Zhang) was appointed as the scrutineer for the EGM to scrutinize the votes.

As at the date of EGM, the total number of issued shares in the Company was 995,351,660 Shares, which was the total number of the Shares entitling the Shareholders to attend and vote for or against or abstain from voting on the proposed

1

resolutions set out in the Notice.

As at the date of EGM and as stated in the Circular, the Connected Customer Shareholder is an executive Director and the chairman of the Board, who indirectly

holds 617,772,578 Shares, representing 62.07 of the entire issued share capital of the Company. The Connected Customer Shareholder and his associates are required to abstain from voting in respect of the resolution(s) approving the New Framework Service Agreement and the transactions contemplated thereunder at the EGM and have been so abstained. Therefore, the total number of Shares held by the Independent Shareholders who were entitled to attend and vote for or against the ordinary resolution proposed at the EGM was 377,579,082.

Save for the aforesaid and to the best knowledge of the Company, as at the date of EGM, no other Shareholder has material interest in the New Framework Service Agreement and therefore no other Shareholder is required to abstain from voting on the proposed resolution approving the New Framework Service Agreement and the transactions contemplated thereunder at the EGM. Save as disclosed above, to the best of the Directors' knowledge, information and belief, having made all reasonable enquires, there were no restrictions on any Shareholders to cast votes on the proposed resolution at the EGM, and there were no Shares entitling the holder to attend and vote only against the resolution proposed at the EGM.

The Board is pleased to announce that the proposed resolution as set out in the Notice was duly passed by the Independent Shareholders by way of poll at the EGM. The poll results in respect of the proposed resolution were as follows:

Resolutions

Number of Votes (%)

For

Against

1.

To approve the New Framework Service Agreement;

19276500

0

100%

(0%)

2.

The proposed annual caps, both annual cap and percentage

19276500

0

cap, in relation to the transactions contemplated under the

New Framework Service Agreement for the period from

100%

(0%)

the date of the extraordinary general meeting and ending

31 December 2024 be and are hereby approved;

3.

Any one Director be and is hereby authorised to do all such

19276500

0

acts or things, as he/she may in his/her absolute discretion

consider necessary or desirable, to give implement and

100%

(0%)

2

effect to the New Framework Service Agreement and the transactions contemplated thereunder.

Note: For the full text of the proposed resolutions, please refer to the Notice.

By order of the Board

China Health Group Inc.

William Xia GUO

Chairman

Hong Kong, 12 July 2022

As at the date hereof, the Board comprises two executive directors, being Mr. William Xia GUO and Dr. Maria Xue Mei Song; one non-executive director, being Ms. Li ZHANG; and three independent non-executive directors, being Mr. Rui QIU, Dr. Bin Hui Ni and Mr. Ling ZHEN..

This announcement for which the directors (the " Directors " ) of China Health Group Inc. (the

  • Company " ) collectively and individually accept full responsibility, includes particulars given in compliance with the Rules Governing the Listing of Securities on the Growth Enterprise Market of the

Stock Exchange (the "GEM Listing Rules ") for the purpose of giving information with regard to China Health Group Inc. The Directors, having made all reasonable enquires, confirm that, to the best of their knowledge and belief: (1) the information contained in this announcement is accurate and complete in all material respects and not misleading; (2) there are no other matters the omission of which would make any statement in this announcement misleading; and (3) all opinions expressed in this announcement have been arrived at after due and careful consideration and are founded on bases and assumptions that are fair and reasonable.

This announcement will remain on the GEM website with the domain name of https://www.hkgem.com on the "Latest Company Announcements" page for at least 7days from the date of its posting and on the Company's website at http://www.chgi.net.

3

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

China Health Group Inc. published this content on 12 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 July 2022 07:23:09 UTC.